On this page

Tubersol

Tuberculin, Purified Protein Derivative

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Tubersol

Proper name

Tuberculin, Purified Protein Derivative

Licence type

351(a)

BLA number

103941

Applicant

Sanofi Vaccines Canada Ltd.

Center

CBER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
5TU/.1ML	Injection	Intradermal	Multi-Dose Vial	Rx	February 24, 2000

Purple Book	FDA	Licence type, presentations, reference product, exclusivity